Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2a study of PH-797804 in post-herpetic neuralgia
2007-005781-12Phase 2Completed
- Sponsor
- Pfizer
- Start
- Nov 2007
- Modality
- Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in postherpetic neuralgia (PHN) comparing PH-797804 with Placebo (2 arms). Primary endpoint: Daily Pain Rating Scale. Started Nov 2007; status: completed.
02
Drugs
PH-797804
03
Conditions
postherpetic neuralgia (PHN)
Beyond the preview
Go deeper on 2007-005781-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-005781-12.